nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—urine—polycystic ovary syndrome	0.0411	0.136	CbGeAlD
Dabigatran etexilate—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.015	0.0798	CcSEcCtD
Dabigatran etexilate—UGT2B15—endocrine gland—polycystic ovary syndrome	0.0124	0.0413	CbGeAlD
Dabigatran etexilate—CES2—adrenal cortex—polycystic ovary syndrome	0.0121	0.0403	CbGeAlD
Dabigatran etexilate—NQO2—adrenal cortex—polycystic ovary syndrome	0.0109	0.036	CbGeAlD
Dabigatran etexilate—CES2—endometrium—polycystic ovary syndrome	0.0108	0.036	CbGeAlD
Dabigatran etexilate—CES2—uterus—polycystic ovary syndrome	0.00999	0.0331	CbGeAlD
Dabigatran etexilate—CES2—pituitary gland—polycystic ovary syndrome	0.00981	0.0325	CbGeAlD
Dabigatran etexilate—CES2—adipose tissue—polycystic ovary syndrome	0.00977	0.0324	CbGeAlD
Dabigatran etexilate—NQO2—endometrium—polycystic ovary syndrome	0.00969	0.0321	CbGeAlD
Dabigatran etexilate—UGT1A9—endocrine gland—polycystic ovary syndrome	0.00943	0.0313	CbGeAlD
Dabigatran etexilate—Contusion—Metformin—polycystic ovary syndrome	0.00906	0.0481	CcSEcCtD
Dabigatran etexilate—Chest discomfort—Metformin—polycystic ovary syndrome	0.00893	0.0474	CcSEcCtD
Dabigatran etexilate—NQO2—uterus—polycystic ovary syndrome	0.00893	0.0296	CbGeAlD
Dabigatran etexilate—NQO2—pituitary gland—polycystic ovary syndrome	0.00877	0.0291	CbGeAlD
Dabigatran etexilate—CES2—adrenal gland—polycystic ovary syndrome	0.00877	0.0291	CbGeAlD
Dabigatran etexilate—NQO2—adipose tissue—polycystic ovary syndrome	0.00873	0.029	CbGeAlD
Dabigatran etexilate—CES2—female gonad—polycystic ovary syndrome	0.00817	0.0271	CbGeAlD
Dabigatran etexilate—CES2—vagina—polycystic ovary syndrome	0.00812	0.0269	CbGeAlD
Dabigatran etexilate—CES1—adipose tissue—polycystic ovary syndrome	0.00805	0.0267	CbGeAlD
Dabigatran etexilate—F2—adrenal gland—polycystic ovary syndrome	0.00786	0.0261	CbGeAlD
Dabigatran etexilate—NQO2—adrenal gland—polycystic ovary syndrome	0.00783	0.026	CbGeAlD
Dabigatran etexilate—UGT2B7—endocrine gland—polycystic ovary syndrome	0.0076	0.0252	CbGeAlD
Dabigatran etexilate—CES2—endocrine gland—polycystic ovary syndrome	0.0076	0.0252	CbGeAlD
Dabigatran etexilate—F2—female gonad—polycystic ovary syndrome	0.00733	0.0243	CbGeAlD
Dabigatran etexilate—NQO2—female gonad—polycystic ovary syndrome	0.0073	0.0242	CbGeAlD
Dabigatran etexilate—NQO2—vagina—polycystic ovary syndrome	0.00726	0.0241	CbGeAlD
Dabigatran etexilate—CES1—adrenal gland—polycystic ovary syndrome	0.00722	0.0239	CbGeAlD
Dabigatran etexilate—F2—endocrine gland—polycystic ovary syndrome	0.00682	0.0226	CbGeAlD
Dabigatran etexilate—NQO2—endocrine gland—polycystic ovary syndrome	0.00679	0.0225	CbGeAlD
Dabigatran etexilate—CES1—female gonad—polycystic ovary syndrome	0.00673	0.0223	CbGeAlD
Dabigatran etexilate—CES1—endocrine gland—polycystic ovary syndrome	0.00626	0.0208	CbGeAlD
Dabigatran etexilate—Pain in extremity—Metformin—polycystic ovary syndrome	0.00574	0.0304	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0053	0.0281	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00524	0.0278	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00513	0.0272	CcSEcCtD
Dabigatran etexilate—Influenza—Metformin—polycystic ovary syndrome	0.00496	0.0263	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Metformin—polycystic ovary syndrome	0.00483	0.0256	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00475	0.0252	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00461	0.0245	CcSEcCtD
Dabigatran etexilate—Infestation—Metformin—polycystic ovary syndrome	0.00442	0.0235	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Metformin—polycystic ovary syndrome	0.00442	0.0235	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00418	0.0222	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00391	0.0207	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0039	0.0207	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00368	0.0195	CcSEcCtD
Dabigatran etexilate—Angiopathy—Metformin—polycystic ovary syndrome	0.0036	0.0191	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Metformin—polycystic ovary syndrome	0.00358	0.019	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00358	0.019	CcSEcCtD
Dabigatran etexilate—Malnutrition—Metformin—polycystic ovary syndrome	0.00345	0.0183	CcSEcCtD
Dabigatran etexilate—Flatulence—Metformin—polycystic ovary syndrome	0.0034	0.0181	CcSEcCtD
Dabigatran etexilate—Syncope—Metformin—polycystic ovary syndrome	0.0031	0.0164	CcSEcCtD
Dabigatran etexilate—Palpitations—Metformin—polycystic ovary syndrome	0.00305	0.0162	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00304	0.0161	CcSEcCtD
Dabigatran etexilate—Hypertension—Metformin—polycystic ovary syndrome	0.00298	0.0158	CcSEcCtD
Dabigatran etexilate—Chest pain—Metformin—polycystic ovary syndrome	0.00294	0.0156	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00292	0.0155	CcSEcCtD
Dabigatran etexilate—ABCB1—embryo—polycystic ovary syndrome	0.00286	0.00948	CbGeAlD
Dabigatran etexilate—Infection—Metformin—polycystic ovary syndrome	0.0028	0.0149	CcSEcCtD
Dabigatran etexilate—Shock—Metformin—polycystic ovary syndrome	0.00277	0.0147	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00276	0.0147	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00276	0.0147	CcSEcCtD
Dabigatran etexilate—Skin disorder—Metformin—polycystic ovary syndrome	0.00274	0.0145	CcSEcCtD
Dabigatran etexilate—Hypotension—Metformin—polycystic ovary syndrome	0.00263	0.014	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00257	0.0136	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00251	0.0133	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00248	0.0132	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00243	0.0129	CcSEcCtD
Dabigatran etexilate—Fatigue—Metformin—polycystic ovary syndrome	0.00243	0.0129	CcSEcCtD
Dabigatran etexilate—Constipation—Metformin—polycystic ovary syndrome	0.00241	0.0128	CcSEcCtD
Dabigatran etexilate—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00234	0.00777	CbGeAlD
Dabigatran etexilate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00231	0.0122	CcSEcCtD
Dabigatran etexilate—Urticaria—Metformin—polycystic ovary syndrome	0.00224	0.0119	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Metformin—polycystic ovary syndrome	0.00223	0.0118	CcSEcCtD
Dabigatran etexilate—ABCB1—endometrium—polycystic ovary syndrome	0.00209	0.00694	CbGeAlD
Dabigatran etexilate—Asthenia—Metformin—polycystic ovary syndrome	0.00202	0.0107	CcSEcCtD
Dabigatran etexilate—Pruritus—Metformin—polycystic ovary syndrome	0.00199	0.0106	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00193	0.0102	CcSEcCtD
Dabigatran etexilate—ABCB1—uterus—polycystic ovary syndrome	0.00193	0.00639	CbGeAlD
Dabigatran etexilate—ABCB1—pituitary gland—polycystic ovary syndrome	0.00189	0.00628	CbGeAlD
Dabigatran etexilate—ABCB1—adipose tissue—polycystic ovary syndrome	0.00188	0.00625	CbGeAlD
Dabigatran etexilate—Dizziness—Metformin—polycystic ovary syndrome	0.00186	0.0099	CcSEcCtD
Dabigatran etexilate—Vomiting—Metformin—polycystic ovary syndrome	0.00179	0.00951	CcSEcCtD
Dabigatran etexilate—Rash—Metformin—polycystic ovary syndrome	0.00178	0.00944	CcSEcCtD
Dabigatran etexilate—Dermatitis—Metformin—polycystic ovary syndrome	0.00178	0.00943	CcSEcCtD
Dabigatran etexilate—Headache—Metformin—polycystic ovary syndrome	0.00177	0.00937	CcSEcCtD
Dabigatran etexilate—ABCB1—adrenal gland—polycystic ovary syndrome	0.00169	0.00561	CbGeAlD
Dabigatran etexilate—Nausea—Metformin—polycystic ovary syndrome	0.00167	0.00889	CcSEcCtD
Dabigatran etexilate—ABCB1—female gonad—polycystic ovary syndrome	0.00158	0.00523	CbGeAlD
Dabigatran etexilate—ABCB1—vagina—polycystic ovary syndrome	0.00157	0.0052	CbGeAlD
Dabigatran etexilate—ABCB1—endocrine gland—polycystic ovary syndrome	0.00147	0.00486	CbGeAlD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000441	0.000864	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000438	0.000858	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000437	0.000857	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000436	0.000855	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—polycystic ovary syndrome	0.000435	0.000853	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000432	0.000847	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKR1C1—polycystic ovary syndrome	0.000431	0.000846	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000426	0.000836	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ISYNA1—polycystic ovary syndrome	0.000415	0.000814	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000415	0.000814	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL6—polycystic ovary syndrome	0.000415	0.000814	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—POMC—polycystic ovary syndrome	0.000414	0.000812	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00041	0.000804	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000405	0.000795	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000401	0.000785	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000399	0.000782	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000398	0.000779	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000397	0.000778	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SULT2A1—polycystic ovary syndrome	0.000397	0.000778	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000387	0.000758	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000386	0.000757	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—RRM2—polycystic ovary syndrome	0.000384	0.000754	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000379	0.000742	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—YAP1—polycystic ovary syndrome	0.000371	0.000727	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00037	0.000726	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000365	0.000715	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SUOX—polycystic ovary syndrome	0.000363	0.000712	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000363	0.000712	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLAT—polycystic ovary syndrome	0.000362	0.00071	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000362	0.00071	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000358	0.000703	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NAMPT—polycystic ovary syndrome	0.000356	0.000698	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TEAD2—polycystic ovary syndrome	0.000353	0.000692	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKR1C2—polycystic ovary syndrome	0.000353	0.000692	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP11A1—polycystic ovary syndrome	0.000352	0.000689	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000351	0.000688	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00035	0.000686	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000349	0.000685	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000349	0.000685	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000347	0.00068	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000339	0.000665	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000338	0.000662	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—POMC—polycystic ovary syndrome	0.000337	0.00066	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000335	0.000658	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKR1C3—polycystic ovary syndrome	0.000332	0.000651	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000332	0.000651	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000331	0.000649	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00033	0.000647	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00033	0.000647	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000329	0.000645	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP17A1—polycystic ovary syndrome	0.000327	0.000641	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000325	0.000637	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.00032	0.000627	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000319	0.000625	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000317	0.000621	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000315	0.000618	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000311	0.00061	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000311	0.000609	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00031	0.000608	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000308	0.000604	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000308	0.000604	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000303	0.000595	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PNPLA2—polycystic ovary syndrome	0.000296	0.00058	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000295	0.000579	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000295	0.000579	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000292	0.000573	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000292	0.000573	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000292	0.000573	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000287	0.000563	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TEAD2—polycystic ovary syndrome	0.000287	0.000563	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000285	0.000559	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—TH—polycystic ovary syndrome	0.000283	0.000555	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000282	0.000552	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000281	0.000551	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000281	0.00055	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—GNAS—polycystic ovary syndrome	0.000278	0.000545	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000276	0.000541	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000276	0.000541	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC2A4—polycystic ovary syndrome	0.000275	0.000539	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000275	0.000539	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000273	0.000536	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000272	0.000533	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—STAR—polycystic ovary syndrome	0.000268	0.000525	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000265	0.00052	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000265	0.00052	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP19A1—polycystic ovary syndrome	0.000259	0.000507	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000258	0.000506	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000252	0.000493	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000241	0.000472	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMMR—polycystic ovary syndrome	0.000239	0.000468	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000235	0.00046	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GNAS—polycystic ovary syndrome	0.000231	0.000453	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00023	0.00045	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000229	0.000449	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000228	0.000448	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000228	0.000447	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000228	0.000446	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NCOR1—polycystic ovary syndrome	0.00022	0.000431	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—STAR—polycystic ovary syndrome	0.000218	0.000426	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000215	0.000422	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000214	0.000419	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000209	0.000411	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000209	0.000409	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP1A1—polycystic ovary syndrome	0.000209	0.000409	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000208	0.000408	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LHB—polycystic ovary syndrome	0.000208	0.000407	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000203	0.000398	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000201	0.000394	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000196	0.000385	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000196	0.000384	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000196	0.000384	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MTHFR—polycystic ovary syndrome	0.000194	0.000381	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMMR—polycystic ovary syndrome	0.000194	0.00038	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FST—polycystic ovary syndrome	0.000191	0.000374	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00019	0.000372	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000188	0.000369	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000186	0.000365	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000185	0.000363	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000183	0.000358	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000182	0.000357	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000182	0.000357	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000181	0.000354	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000181	0.000354	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF1—polycystic ovary syndrome	0.00018	0.000353	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT2—polycystic ovary syndrome	0.00018	0.000353	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000176	0.000345	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000176	0.000345	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—RRM2—polycystic ovary syndrome	0.000175	0.000343	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000174	0.000342	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000173	0.00034	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000172	0.000337	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000172	0.000336	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000171	0.000335	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—YAP1—polycystic ovary syndrome	0.000169	0.000331	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LHB—polycystic ovary syndrome	0.000169	0.000331	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000167	0.000327	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000167	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000166	0.000326	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000165	0.000323	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000163	0.000321	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NAMPT—polycystic ovary syndrome	0.000162	0.000318	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000162	0.000318	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000161	0.000316	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP11A1—polycystic ovary syndrome	0.00016	0.000314	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKR1C1—polycystic ovary syndrome	0.00016	0.000313	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00016	0.000313	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—polycystic ovary syndrome	0.000158	0.000309	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—polycystic ovary syndrome	0.000155	0.000305	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000155	0.000304	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—INS—polycystic ovary syndrome	0.000155	0.000303	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000151	0.000297	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000151	0.000297	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000149	0.000293	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000149	0.000292	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000147	0.000289	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000147	0.000288	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—INS—polycystic ovary syndrome	0.000147	0.000287	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000143	0.00028	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—RRM2—polycystic ovary syndrome	0.000142	0.000279	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000142	0.000278	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	0.000137	0.000269	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000137	0.000268	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000136	0.000266	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000133	0.000262	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000132	0.000259	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	0.000132	0.000258	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000132	0.000258	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000132	0.000258	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000131	0.000257	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	0.00013	0.000255	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000129	0.000253	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TH—polycystic ovary syndrome	0.000129	0.000253	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000125	0.000246	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000123	0.000241	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000123	0.000241	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000123	0.000241	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000121	0.000237	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000119	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000118	0.000232	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000118	0.000231	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—polycystic ovary syndrome	0.000118	0.000231	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000117	0.00023	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000117	0.00023	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000114	0.000224	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000114	0.000223	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00011	0.000216	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000109	0.000214	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000108	0.000212	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000107	0.000211	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000107	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	0.000105	0.000206	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.000105	0.000205	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000105	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000103	0.000203	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000102	0.0002	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000102	0.000199	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	0.0001	0.000196	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—STAR—polycystic ovary syndrome	9.98e-05	0.000196	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.98e-05	0.000196	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	9.58e-05	0.000188	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	9.5e-05	0.000186	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.43e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.98e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	8.92e-05	0.000175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	8.89e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	8.86e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.82e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	8.55e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	8.48e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.37e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	8.14e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LHB—polycystic ovary syndrome	7.74e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	7.56e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.55e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—polycystic ovary syndrome	7.39e-05	0.000145	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	7.32e-05	0.000144	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	7.18e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	7.08e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—polycystic ovary syndrome	7.04e-05	0.000138	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	6.74e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.59e-05	0.000129	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	6.53e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—polycystic ovary syndrome	6.35e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—polycystic ovary syndrome	6.31e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	6.29e-05	0.000123	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.11e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.1e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	6.05e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	5.97e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	5.83e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.8e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	5.75e-05	0.000113	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—polycystic ovary syndrome	5.72e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	5.64e-05	0.000111	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	5.55e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TH—polycystic ovary syndrome	4.8e-05	9.42e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	4.67e-05	9.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.67e-05	9.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	4.39e-05	8.61e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.99e-05	7.82e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.92e-05	7.69e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.74e-05	7.32e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.54e-05	6.94e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.3e-05	6.47e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—polycystic ovary syndrome	2.76e-05	5.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.68e-05	5.25e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.64e-05	5.18e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.63e-05	5.15e-05	CbGpPWpGaD
